Drug Allergy: Then, Now, and Next

[1]  E. Phillips,et al.  Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[2]  F. Braido,et al.  Placebo, Nocebo and Patient Reported Outcome Measures in Drug Allergy. , 2022, The journal of allergy and clinical immunology. In practice.

[3]  A. Wurcel,et al.  Penicillin Allergy Evaluation and Health Equity: A Call to Action. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[4]  G. Volcheck,et al.  Perioperative Hypersensitivity Evaluation and Management: A Practical Approach. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[5]  J. Sandoe,et al.  Addressing the challenges of penicillin allergy delabeling with electronic health records and mobile applications. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[6]  J. Bernstein,et al.  Drug Allergy: A 2022 Practice Parameter Update. , 2022, The Journal of allergy and clinical immunology.

[7]  N. Adkinson,et al.  The evolution of our understanding of penicillin allergy: 1942 to 2022. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[8]  S. Yüksel,et al.  Determinants of nocebo effect during oral drug provocation tests. , 2015, Allergologia et immunopathologia.